Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$33.21 - $46.54 $86,744 - $121,562
-2,612 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$33.87 - $55.93 $88,468 - $146,089
2,612 New
2,612 $91,000
Q4 2019

Feb 14, 2020

SELL
$30.08 - $50.59 $34,712 - $58,380
-1,154 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$32.4 - $49.58 $37,389 - $57,215
1,154 New
1,154 $37,000

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $2.3B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.